Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
The aim of study is to evaluate the efficacy and safety of the new generic formulation
(rosuvastatin orally disintegrating tablet (SUVARO®ODT) in patients with dyslipidemia.